A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this ...

On an overcast Tuesday in December, Michael Hale stood before a group of students at the Portland Opportunities Industrial ...

As prevalence of CVDs continues to increase, the AHA and AMA have developed the Target BP initiative to improve blood ...

Chinese scientists have found a common hypertension drug could prove potent in treating a rare but highly invasive brain ...

PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...

People with high blood pressure who slept for shorter durations were more likely to show poor cognitive function and ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair ...

Out of 1.66 crore people aged 30 and above in Telangana, 22.94 lakh suffer from hypertension, while 11.9 lakh have diabetes, ...

Glaucoma, the leading cause of blindness, is often marked by loss of retinal ganglion cells (RGCs). Necroptosis, a form of ...